Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China flag China · Delayed Price · Currency is CNY
18.78
-0.84 (-4.28%)
Apr 3, 2025, 2:45 PM CST

SHE:002755 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Apr '25 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2014 - 2018
Market Capitalization
18,21110,0437,37011,81512,12214,999
Upgrade
Market Cap Growth
30.69%36.27%-37.63%-2.53%-19.18%-
Upgrade
Enterprise Value
16,3688,4335,75710,47710,82113,679
Upgrade
Last Close Price
19.6210.827.9412.6012.7315.56
Upgrade
PE Ratio
110.20--31.1016.8019.21
Upgrade
PS Ratio
10.526.963.943.803.213.32
Upgrade
PB Ratio
6.103.342.453.664.005.96
Upgrade
P/TBV Ratio
3.883.592.573.794.126.18
Upgrade
P/FCF Ratio
65.79--27.2331.8441.03
Upgrade
P/OCF Ratio
25.62--20.8120.8928.06
Upgrade
EV/Sales Ratio
9.585.843.083.372.863.03
Upgrade
EV/EBITDA Ratio
143.44--26.1113.1114.70
Upgrade
EV/EBIT Ratio
264.43--33.8314.7716.23
Upgrade
EV/FCF Ratio
59.13--24.1428.4237.42
Upgrade
Debt / Equity Ratio
0.030.040.020.000.01-
Upgrade
Debt / EBITDA Ratio
0.90--0.030.02-
Upgrade
Debt / FCF Ratio
0.37--0.030.05-
Upgrade
Asset Turnover
0.460.420.530.831.011.36
Upgrade
Inventory Turnover
1.891.801.731.781.581.65
Upgrade
Quick Ratio
3.134.626.055.693.572.21
Upgrade
Current Ratio
3.415.076.606.193.842.44
Upgrade
Return on Equity (ROE)
4.09%-6.89%-8.53%12.16%26.14%35.80%
Upgrade
Return on Assets (ROA)
0.59%-5.23%-5.48%5.14%12.21%15.84%
Upgrade
Return on Capital (ROIC)
0.72%-5.85%-6.20%6.15%16.44%24.15%
Upgrade
Return on Capital Employed (ROCE)
1.10%--9.30%23.50%32.20%
Upgrade
Earnings Yield
0.90%-1.48%-3.06%3.21%5.95%5.21%
Upgrade
FCF Yield
1.52%-1.55%-2.76%3.67%3.14%2.44%
Upgrade
Dividend Yield
0.00%--0.79%1.57%1.41%
Upgrade
Payout Ratio
0.61%--48.89%28.43%14.95%
Upgrade
Buyback Yield / Dilution
-1.56%1.34%-1.55%-0.16%0.49%-23.49%
Upgrade
Total Shareholder Return
-1.56%1.34%-1.55%0.64%2.06%-22.07%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.